 Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1995 | 2 | 4 | 6 | | 1996 | 0 | 4 | 4 | | 1997 | 3 | 1 | 4 | | 1998 | 2 | 2 | 4 | | 1999 | 2 | 2 | 4 | | 2000 | 4 | 2 | 6 | | 2001 | 4 | 4 | 8 | | 2002 | 4 | 1 | 5 | | 2003 | 6 | 2 | 8 | | 2004 | 2 | 4 | 6 | | 2005 | 10 | 1 | 11 | | 2006 | 5 | 3 | 8 | | 2007 | 5 | 1 | 6 | | 2008 | 9 | 7 | 16 | | 2009 | 8 | 7 | 15 | | 2010 | 15 | 6 | 21 | | 2011 | 3 | 9 | 12 | | 2012 | 10 | 5 | 15 | | 2013 | 11 | 11 | 22 | | 2014 | 22 | 12 | 34 | | 2015 | 19 | 7 | 26 | | 2016 | 19 | 10 | 29 | | 2017 | 16 | 9 | 25 | | 2018 | 14 | 13 | 27 | | 2019 | 14 | 7 | 21 | | 2020 | 19 | 15 | 34 | | 2021 | 3 | 4 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Bull TM. Clotting and COVID-19. Chest. 2021 06; 159(6):2151-2152.
-
McCully BH, Wade CE, Fox EE, Inaba K, Cohen MJ, Holcomb JB, Schreiber MA. Temporal profile of the pro- and anti-inflammatory responses to severe hemorrhage in patients with venous thromboembolism: Findings from the PROPPR trial. J Trauma Acute Care Surg. 2021 05 01; 90(5):845-852.
-
Baumann Kreuziger L, Gaddh M, Onadeko O, George G, Wang TF, Oo TH, Jaglal M, Houghton DE, Streiff MB, Gali R, Feng M, Simpson P, Billett HH. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study. Thromb Res. 2021 06; 202:155-161.
-
Faustino EVS, Shabanova V, Raffini LJ, Kandil SB, Li S, Pinto MG, Cholette JM, Hanson SJ, Nellis ME, Silva CT, Chima R, Sharathkumar A, Thomas KA, McPartland T, Tala JA, Spinella PC. Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical Trial. Crit Care Med. 2021 03 01; 49(3):e235-e246.
-
Stillson JE, Bunch CM, Gillespie L, Khan R, Wierman M, Pulvirenti J, Phyu H, Anderson S, Al-Fadhl M, Thomas AV, Kwaan HC, Moore E, Moore H, Walsh MM. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage. Semin Thromb Hemost. 2021 06; 47(4):442-446.
-
Shoamanesh A, Hart RG, Connolly SJ, Kasner SE, Smith EE, Martí-Fàbregas J, Liu YY, Uchiyama S, Mikulik R, Veltkamp R, O'Donnell MJ, Ntaios G, Muir KW, Field TS, Santo GC, Olavarria V, Mundl H, Lutsep H, Berkowitz SD, Sharma M. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2021 01 01; 78(1):11-20.
-
Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernán MA, Leaf DE. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 01 01; 181(1):41-51.
-
Connor P, Sánchez van Kammen M, Lensing AWA, Chalmers E, Kállay K, Hege K, Simioni P, Biss T, Bajolle F, Bonnet D, Grunt S, Kumar R, Lvova O, Bhat R, Van Damme A, Palumbo J, Santamaria A, Saracco P, Payne J, Baird S, Godder K, Labarque V, Male C, Martinelli I, Morales Soto M, Motwani J, Shah S, Hooimeijer HL, Prins MH, Kubitza D, Smith WT, Berkowitz SD, Pap AF, Majumder M, Monagle P, Coutinho JM. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). Blood Adv. 2020 12 22; 4(24):6250-6258.
-
Garg J, Shah S, Shah K, Turagam MK, Tzou W, Natale A, Lakkireddy D. Direct Oral Anticoagulant Versus Warfarin for Watchman Left Atrial Appendage Occlusion-Systematic Review: Electram Investigators. JACC Clin Electrophysiol. 2020 12 14; 6(13):1735-1737.
-
Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy. 2020 11; 40(11):1130-1151.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|